Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
The threat follows days of long lines at airports and comes as TSA workers approach their second month without a paycheck. by Rebecca Schneid by Rebecca Schneid Jim Watson—Getty Images by Callum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results